市場調査レポート

商品コード

1619304

インスリンペンの市場規模、シェア、成長分析、タイプ別、最終用途別、地域別 - 産業別予測、2024～2031年

Insulin Pens Market Size, Share, Growth Analysis, By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare), By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 766,592円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 896,768円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,026,944円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.64円

全表示
概要
目次

概要

サンプル依頼リストに入れる

インスリンペンの世界市場規模は2022年に62億米ドルと評価され、2023年の77億3,000万米ドルから2031年には448億8,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは24.6%で成長する見通しです。

インスリンペンの世界市場は、糖尿病有病率の上昇と、使いやすく便利なデリバリー方法によるインスリンペンの採用増加により、力強い成長を遂げています。これらのペンは、その使いやすさ、正確な投与、携帯性から、特に発展途上国で増加する糖尿病患者の間で支持されています。Bluetooth接続やデータ追跡機能などの技術的進歩とともに、糖尿病管理における利点が認識され、市場拡大をさらに後押ししています。しかし、低所得地域での利用を制限する先進モデルの高価格、一部の地域における不十分なヘルスケアインフラ、メーカーが品質基準への準拠を確保するために通過しなければならない規制の複雑さなどの課題も残っています。市場の持続的成長には、こうした課題に対処することが不可欠です。

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Ypsomed Holding AG
BD（Becton, Dickinson and Company）
Owen Mumford Ltd
Haselmeier AG
Medtronic plc
Emperra GmbH E-Health Technologies
Diamesco Co., Ltd.
MANNKind Corporation
Jiangsu Delfu Medical Device Co., Ltd.
Pendiq GmbH
Sensile Medical AG
Injex Pharma AG
Copernicus Sp. z o.o.
Wockhardt Ltd

結論と推奨事項

Product Code: SQMIG35B2138

Global Insulin Pens Market size was valued at USD 6.2 billion in 2022 and is poised to grow from USD 7.73 billion in 2023 to USD 44.88 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global insulin pens market is experiencing robust growth, driven by the rising prevalence of diabetes and the increasing adoption of insulin pens for their user-friendly and convenient delivery method. These pens are favored for their ease of use, precise dosing, and portability, particularly among the growing diabetic population in developing countries. Awareness of their benefits in diabetes management, alongside technological advancements-such as Bluetooth connectivity and data tracking features-has further propelled market expansion. However, challenges remain, including high costs of advanced models limiting accessibility in low-income regions, inadequate healthcare infrastructure in some areas, and regulatory complexities that manufacturers must navigate to ensure compliance with quality standards. Addressing these challenges is critical for sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

Global Insulin Pens Market is segmented by Type, End-use, and region. Based on Type, the market is segmented into Reusable Insulin Pens, and Disposable Insulin Pens. Based on End-use, the market is segmented into Hospitals & Clinics, Homecare, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pens Market

The Global Insulin Pens market is significantly propelled by ongoing technological advancements within insulin pen devices. Innovations such as Bluetooth connectivity, built-in memory functions, and the emergence of smart insulin pens contribute to an enhanced user experience and more effective treatment outcomes. These modern features not only make it easier for patients to manage their diabetes but also promote adherence to treatment regimens. As patients increasingly seek devices that offer both convenience and functionality, these technological improvements are expected to fuel market growth, making insulin pens more appealing and accessible to a wider range of consumers.

Restraints in the Global Insulin Pens Market

The Global Insulin Pens market faces certain constraints primarily due to needle phobia and resistance among some individuals. This aversion to needles can significantly hinder the acceptance and utilization of insulin pens, as many people experience anxiety or fear associated with self-injection. Such apprehensions often lead to decreased adherence to treatment regimens and a preference for alternative methods of insulin delivery. Consequently, the presence of needle-related fears may result in an overall reluctance to adopt insulin pens, posing challenges for market growth and the effective management of diabetes among affected individuals.

Market Trends of the Global Insulin Pens Market

The Global Insulin Pens market is witnessing a significant trend towards customization and personalization, driven by the increasing demand for products that cater to individual patient needs. Manufacturers are responding by offering a variety of options, including a spectrum of colors, adjustable dose settings, and personalized branding features. This movement not only aims to enhance patient engagement and satisfaction but also fosters a sense of ownership among users, making insulin management more user-friendly. As awareness of diabetes continues to rise globally, the push for tailored solutions is expected to dominate the market, influencing product development and healthcare strategies in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies
Customer & Buying Criteria Analysis

Global Insulin Pens Market Size by Type & CAGR (2024-2031)

Market Overview
Reusable Insulin Pens
Disposable Insulin Pens

Global Insulin Pens Market Size by End-use & CAGR (2024-2031)

Market Overview
Hospitals & Clinics
Homecare
Others

Global Insulin Pens Market Size & CAGR (2024-2031)

North America, (Type, End-use)
- US
- Canada
Europe, (Type, End-use)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa, (Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haselmeier AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diamesco Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MANNKind Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Medical Device Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pendiq GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensile Medical AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Injex Pharma AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Copernicus Sp. z o.o.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

インスリンペンの市場規模、シェア、成長分析、タイプ別、最終用途別、地域別 - 産業別予測、2024～2031年

Insulin Pens Market Size, Share, Growth Analysis, By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

インスリンペン市場規模：タイプ別

インスリンペン市場規模：最終用途別

インスリンペン市場規模：地域別